The US Food and Drug Administration has granted Elon Musk’s company Neuralink approval to begin human trials on brain chips.
Twitter and SpaceX’s billionaire owner took to social media this week to congratulate Neuralink on the news. The company has been striving for this moment for six years, but the FDA issued some warnings that Neuralink will have to address ongoing concerns, including the safety of the lithium batteries contained within the device.
